GlassScriptPhysician profile
Mehul M Mehta
NPI 1770575763
$5,875.49
in general payments reported to CMS, 2019-2025
23 companies · $867 in 2025
The $867 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $184 · 2021: $191 · 2022: $1,147 · 2023: $2,193 · 2024: $905 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,616 · Travel and Lodging: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,615.84 |
| Travel and Lodging | $1,349.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,092.24 | 2019-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Endo Pharmaceuticals INC. | $1,066.15 | 2019-2024 | Xiaflex |
| Pinnacle, INC | $1,045.21 | 2019-2023 | |
| Arthrex, INC. | $661.16 | 2019-2023 | |
| Stryker Corporation | $452.32 | 2022-2025 | Variax, Bio4, Fixos |
| Aroa Biosurgery Incorporated | $335.30 | 2024-2025 | |
| Amgen INC. | $165.87 | 2025 | Krystexxa, Evenity |
| Integra Lifesciences Corporation | $150.47 | 2021-2023 | Tenoglide |
| Depuy Synthes Sales INC. | $124.87 | 2024 | Fibergraft Bg Morsels |
| Endo USA, INC. | $122.69 | 2024-2025 | Xiaflex |
| Musculoskeletal Transplant Foundation INC. | $114.63 | 2022 | |
| Horizon Therapeutics Plc | $109.80 | 2023 | Krystexxa |
| Medartis INC. | $100.00 | 2025 | Aptus |
| Acera Surgical, INC. | $99.45 | 2024 | Restrata Wound Matrix |
| Globus Medical, INC. | $50.82 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $48.27 | 2025 | Novosorb Btm |
| Sientra, INC. | $28.88 | 2022 | |
| Orthofix Medical, INC. | $23.67 | 2020-2022 | |
| Checkpoint Surgical, INC | $20.27 | 2023 | Checkpoint Stimulators |
| Organogenesis INC. | $19.20 | 2024 | Apligraf |
| Djo, LLC | $17.70 | 2023 | Cmf |
| Vertex Pharmaceuticals Incorporated | $15.12 | 2025 | |
| Anika Therapeutics, INC. | $11.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehul Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.